KBI Biopharma

Analytics isn’t just data - it’s the key to hitting milestones on-time. At KBI Biopharma, we make analytics a decision driver at every stage, from structure prediction to commercial-scale manufacturing. Our phase-specific, interdisciplinary lifecycle approach ensures robust, scalable, and reproducible processes that de-risk development and accelerate timelines. With world-class expertise in biophysical characterization, mass spectrometry, cell-based assays, and process validation, we help you generate the right data, at the right time, to move your biotherapeutic forward with confidence. Looking for a global analytical partner? Let’s get your molecule market-ready. https://lnkd.in/edzC53uB #biotherapeutics #KBIBiopharma

Join KBI Biopharma at American Biomanufacturing Summit in San Francisco!  Don't miss our Group Leader and Senior Scientist Dane Grismer, Ph.D., on Day 1 as he presents: “Smarter Process Development: Leveraging Tested Workflows to Accelerate Your Biologic Development”, discussing how KBI Biopharma’s unique capabilities enable a significantly faster path to first-in-human studies. Our team will also be available at booth 18, so come along to learn how we help clients advance drug candidates into the clinic and beyond. Find out more, or schedule a meeting: https://lnkd.in/ee-geDPP  #KBIBiopharma

As Pharma 4.0 moves closer to its promise of streamlining drug development, improving process and product quality, and optimizing CDMO/customer interactions, KBI Biopharma is spearheading the paradigm shift. With the development of PROGRAMview – our digital collaboration software – we’re rewriting the rulebook with an entirely new, customer-centric approach to the CDMO experience. Access the article to learn more about how we’re driving change from the frontline: https://lnkd.in/e8nPEq3E #KBIBiopharma #drugdevelopment #CDMO Outsourced Pharma

Did you hear the news? KBI Biopharma has been awarded a prestigious CDMO Leadership Award in the Biologics - Global category! Our sincerest thanks to Outsourced Pharma / Life Science Connect for this honor; we are delighted to be recognized for advancing biologics in these critical areas. The awards identify the top CDMOs worldwide based on in-depth customer feedback and evaluations, underscoring the impact of our collaborations with industry peers. Check out what our CEO Tim Lowery had to say about the win: https://lnkd.in/evzb-Sib #KBIBiopharma #Biologics

Introducing PROGRAMview™ - KBI Biopharma’s new digital client collaboration platform bridging the data access gap between labs and project stakeholders. PROGRAMview brings transparency and efficiency to drug development, empowering teams to make faster, data-driven decisions. With PROGRAMview, you can:  - Access real-time data from our facilities without the back-and-forth emails  - Centralize and navigate data across departments, including process and analytical development  - Trend, summarize, and share project insights effortlessly  - Collaborate effectively with built-in commenting and @ mentions for streamlined discussions Take the next step toward smarter collaboration and transparency in drug development. Learn more about PROGRAMview: https://lnkd.in/gvnfRcBy #DrugDevelopment #Biologics #KBIBiopharma 

What a week at ACS Spring 2025! Our scientists took the stage (and the poster hall) to showcase new innovations in bioprocessing - from continuous clarification and high-density cultures to advanced conjugates and manufacturing strategies. We loved the energy, the science, and the great conversations. Thanks to everyone who joined us in San Diego! Quan Zhou Thomas Lindsey Heather Horne Jake Daehong Kim Mark Conrad #ACSSpring #KBIBiopharma

Navigating purity, achieving high titers, and simplifying downstream processing can feel like an uphill battle, but it doesn't have to be. In our whitepaper, experts Erik Nordwald, Ph.D. and Tyler Telander, MS break down how KBI Biopharma’s innovative PUREplatfrom(TM) tackles these challenges head-on, delivering high-titer, stable expression with fewer impurities right from the start. Get insights on creating a proactive microbial "factory," leveraging high-throughput screening, and redefining scalability to streamline your development timelines. Download your copy here: https://lnkd.in/eEqJ6NjN #KBIBiopharma #MicrobialManufacturing #Bioprocessing

What does true CDMO efficiency look like? It’s more than just speed, it’s about flexible platforms, digital tools, and seamless data access. In this webinar, Erik Nordwald, Shaunak Uplekar, and Marlee Paulson break down how KBI Biopharma is optimizing biologics development with: • Scalable, adaptable platforms that reduce risk and streamline workflows • Integrated digital solutions, like PROGRAMview™, for real-time process insights • Tailored process development strategies designed to maximize efficiency Discover how KBI’s innovative approach to CDMO flexibility is transforming biomanufacturing. Watch the full webinar on demand: https://lnkd.in/gfHjYMuM #KBIBiopharma #CDMO #Biomanufacturing

Innovation is redefining the path to first-in-human (FIH) trials. From cell line development breakthroughs to smarter process development workflows, biopharma teams are pushing boundaries to accelerate timelines and improve efficiency -- but are you keeping up? Hear from our experts and discover how KBI Biopharma’s SUREtechnology Platform™, powered by Selexis®, can help to streamline your journey to FIH, without compromising quality or scalability. Don’t miss this insightful session -- watch now: https://lnkd.in/gReqh_u3 #BiopharmaInnovation #FIHTrials #KBIBiopharma

Happening now at BPI West: Romone Fancy, Ph.D., presenting 'Improving Chromatography Column Purification Efficiency with OMEGA Column Inserts.' #BPIWest2025 #KBIBiopharma